OTCMKTS:SGIOY Shionogi & Co., Ltd. Unsponsored ADR Q1 2027 Earnings Results & Report $9.95 +0.09 (+0.86%) As of 11:10 AM Eastern Shionogi & Co., Ltd. Unsponsored ADR beat analyst expectations on both earnings and revenue in its Q1 2027 results, released August 3, 2026. The company reported EPS of $0.36 versus the $0.18 consensus estimate, while revenue of $1.04 billion topped the $970.69 million estimate by $72.32 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2027Report DateAugust 3, 2026TimeAfter Market Closes Shionogi & Co., Ltd. Unsponsored ADR EPS ResultsActual EPS$0.36Consensus EPS $0.18Beat/MissBeat by +$0.18One Year Ago EPSN/AEPS Beat Rate5 of last 8 quartersShionogi & Co., Ltd. Unsponsored ADR Revenue ResultsActual Revenue$1.04 billionExpected Revenue$970.69 millionBeat/MissBeat by +$72.32 millionYoY Revenue GrowthN/AUpcoming EarningsShionogi & Co., Ltd. Unsponsored ADR's next earnings date is estimated for Friday, January 29, 2027, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Shionogi & Co., Ltd. Unsponsored ADR Q1 2027 Earnings FAQ Did Shionogi & Co., Ltd. Unsponsored ADR beat earnings estimates for Q1 2027? Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) reported earnings of $0.36 per share for Q1 2027, beating the consensus estimate of $0.18. The report was announced on Monday, August 3, 2026. What was Shionogi & Co., Ltd. Unsponsored ADR's revenue for Q1 2027? Shionogi & Co., Ltd. Unsponsored ADR reported revenue of $1.04 billion for Q1 2027, against a consensus estimate of $970.69 million. When is Shionogi & Co., Ltd. Unsponsored ADR's next earnings date? Shionogi & Co., Ltd. Unsponsored ADR's next earnings date is estimated for Friday, January 29, 2027. MarketBeat tracks confirmed and estimated earnings dates for Shionogi & Co., Ltd. Unsponsored ADR on the company's earnings history page. Shionogi & Co., Ltd. Unsponsored ADR Earnings HeadlinesReviewing Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) and RYTHM (NASDAQ:RYM)November 9, 2026 | americanbankingnews.comSHIONOGI & CO LTDNovember 1, 2026 | finanznachrichten.deYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.November 16 at 1:00 AM | Profits Run (Ad)Shionogi & Co., Ltd. unsponsored ADR (SGIOY) Q2 earnings lag estimatesOctober 29, 2026 | msn.comShionogi & Co. (SGIOY) Upgraded to Buy: Here's What You Should KnowOctober 14, 2026 | msn.comAll You Need to Know About Shionogi & Co. (SGIOY) Rating Upgrade to BuyFebruary 4, 2026 | msn.comSee More Shionogi & Co., Ltd. Unsponsored ADR Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Shionogi & Co., Ltd. Unsponsored ADR? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Shionogi & Co., Ltd. Unsponsored ADR and other key companies, straight to your email. Email Address About Shionogi & Co., Ltd. Unsponsored ADRShionogi & Co., Ltd. is a Japan-based pharmaceutical company that researches, develops, manufactures and markets prescription medicines. Founded in Osaka in 1878, it has grown from a pharmaceutical wholesaler into a research-focused drugmaker. The company has a particular focus on infectious diseases, including HIV, influenza and COVID-19, and also works in areas such as pain and central nervous system disorders. Its products include Xofluza, an influenza treatment, and ensitrelvir, an oral COVID-19 antiviral marketed in Japan as Xocova. Shionogi serves patients in Japan and international markets through its own operations and collaborations with other pharmaceutical companies. Its partnerships have supported the development and commercialization of medicines in areas including HIV treatment.View Shionogi & Co., Ltd. Unsponsored ADR ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles 3 Building-Materials Stocks Rallying While Homebuilders Struggle to Find BuyersMarketBeat Week in Review – 11/9 - 11/133 AI Hardware Leaders Are Raising Dividends, But Which Offers More Income?Nu Holdings Earnings Show a Compounder Priced Like a Brazil BetCould Big Buybacks Be the Next Catalyst for These 3 AI Stocks?Cerebras Q3 Results: How Much More Proof Does Wall Street Need?Sandisk's Sell-Off May Be Losing Steam, But the Biggest Risk Still Looms Upcoming Earnings Walt Disney (11/17/2026)Home Depot (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.